Loading...
XCNQ
OMND
, Last price  
CAD
Name

Loon Energy Corp

Chart & performance

D1W1MN
XCNQ:OMND chart
P/E
—
P/S
—
EPS
—
Vol. 1Y
—
Shs. 5Y
95.22%
Rev. 5Y
%
Div Yld LY
—
Div Yld TTM
—
Revenues
121k
+2.47%
506,21648,3840000000000099,690170,113122,959118,368121,293
Net income
-118k
L-45.35%
-3,511,000-960,000-2,598,000-1,470,000-568,000-694,000-257,509-126,449-147,000247,195-214,000-25,175131,348-172,232-3,078,000-1,398,000-215,812-117,935
CFO
-215k
L-54.30%
-52,143-98,053-81,501-1,040,974-470,266-214,922

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Optimind Pharma Corp. is a Canadian pharmaceutical enterprise headquartered in Toronto. The company specializes in offering psychedelic-based therapies, including ketamine-assisted treatment and other advanced psychedelic-enhanced psychotherapy modalities, targeting mental health conditions such as post-traumatic stress syndrome, anxiety, depression, and various other psychological disabilities. Additionally, Optimind Pharma operates a dedicated clinic that provides patients with medical cannabis and a range of alternative medical treatments, notably featuring ketamine-enhanced psychotherapy as part of its offerings.

Key people

Timothy Mulroney Elliott
Chairman of the Board · since 2008
Jock Macdonald Graham
Director · since 2008
Norman William Holton
President, Chief Executive Officer, Director
Richard W. Elliott
Independent Director · since 2008
Kenneth R. Heuchert
Independent Director · since 2008
Michael Alexander McVea
Independent Director · since 2009
IPO date
Mar 17, 1998
Employees
Domiciled in
CA
Incorporated in
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑022025‑022024‑022023‑022022‑022020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT